Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New online support programme aims to ease burden on heart failure carers

NCT ID NCT07373041

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a 6-week online support programme called HELP for carers of people with heart failure. Around 180 carers and 180 patients will take part across three UK sites. The programme includes weekly online group sessions led by heart failure nurses, plus an educational booklet and website. Researchers will evaluate how well the programme works and how it can be delivered nationwide.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
HEart faiLure carer support Programme (HELP) - a 6-week psychoeducational intervention with online support groups and educational materials
What this could lead to
If successful, this programme could provide a proven way to support carers of heart failure patients across the UK, improving their well-being and ability to care.
What could go wrong
This is an implementation study, not a large-scale efficacy trial, so results may not show strong benefits. The programme relies on digital access, which may exclude some carers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 360 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Nov 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Carers Inclusion Criteria 1. Aged 18 years or older 2. Physical and mental ability to operate a digital device, engage comfortably in conversation with peers, and be able to read written materials 3. Caring (regular, unpaid care) for a person with a clinical diagnosis of heart failure (HF) who is receiving standard evidence-based HF therapies and has either HF symptoms or 1 episode of decompensation (symptoms requiring medical attention) in previous 6 months 4. Ability to speak and understand English Exclusion criteria 1. Lacking capacity to give consent 2. Under the age of 18 Patients Inclusion Criteria 1. Aged 18 years or older 2. Physical and mental ability to engage comfortably in conversation and be able to read written materials 3. Clinical diagnosis of HF and receiving standard evidence-based HF therapies and has either HF symptoms or 1 episode of decompensation (symptoms requiring medical attention) in previous 6 months 4. Ability to speak and understand English 5. Receiving regular, unpaid support with managing his / her condition from a loved one or friend (e.g., a relative or spouse) Exclusion criteria 1. Lacking capacity to give consent 2. Under the age of 18 3. Carer refused to participate in HELP

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Care givers are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    5 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Craigavon Area Hospital

    NOT_YET_RECRUITING

    Craigavon, United Kingdom

  • Glasgow Royal Infirmary

    RECRUITING

    Glasgow, United Kingdom

  • King's College Hospital

    NOT_YET_RECRUITING

    London, United Kingdom

  • Royal Victoria Hospital

    NOT_YET_RECRUITING

    Belfast, United Kingdom

  • Ulster Hospital

    NOT_YET_RECRUITING

    Belfast, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.